Source:http://linkedlifedata.com/resource/pubmed/id/15611857
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
2005-3-9
|
pubmed:abstractText |
Natural antibodies produced by CD5+ B-1 B cells include those with specificity for senescent erythrocytes (anti-BrMRBC, anti-PtC) and for thymocytes (anti-thymocyte autoantibody, ATA). Here we describe work from our laboratories studying two prototypic examples, V(H)11Vkappa9-encoded anti-BrMRBC and V(H)3609Vkappa21c-encoded ATA. Using V(H)11-mu transgenic mice, we discovered that certain natural autoantibodies utilize V(H) genes that are selected against in bone marrow B cell development, but not fetal liver, effectively restricting their generation to fetal/neonatal life. Studies with ATA-mu transgenic mice demonstrated a critical requirement for self antigen in the accumulation of B cells with this specificity and for the production of high levels of serum ATA. Finally, analysis of B cell development in ATA-mu kappa transgenic mice revealed two distinct responses by B cells to expression of this B cell receptor (BCR): most developing B cells in spleen of adult mice were blocked at an immature stage and only escaped apoptosis by editing their BCR to eliminate the ATA specificity; nevertheless, high levels of serum ATA were observed, indicating that some B cells differentiated to antibody-forming cells without altering their specificity. Thus, our studies reveal mechanisms for restricting the generation of B cells producing natural autoantibodies, demonstrate a key positive selection step in their development, and show that most developing B cells in adult mice bearing such specificities fail to reach a mature stage.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0344-4325
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
26
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
363-75
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:15611857-Animals,
pubmed-meshheading:15611857-Antibody Specificity,
pubmed-meshheading:15611857-Antilymphocyte Serum,
pubmed-meshheading:15611857-Autoantibodies,
pubmed-meshheading:15611857-B-Lymphocyte Subsets,
pubmed-meshheading:15611857-Cell Differentiation,
pubmed-meshheading:15611857-Erythrocyte Aging,
pubmed-meshheading:15611857-Erythrocytes,
pubmed-meshheading:15611857-Immunity, Innate,
pubmed-meshheading:15611857-Mice,
pubmed-meshheading:15611857-Mice, Transgenic,
pubmed-meshheading:15611857-Models, Immunological,
pubmed-meshheading:15611857-Receptors, Antigen, B-Cell,
pubmed-meshheading:15611857-T-Lymphocytes
|
pubmed:year |
2005
|
pubmed:articleTitle |
Development of B cells producing natural autoantibodies to thymocytes and senescent erythrocytes.
|
pubmed:affiliation |
Division of Basic Sciences, Fox Chase Cancer Center, 333 Cottman Ave., Philadelphia, PA 19111, USA. rr_hardy@fccc.edu
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Review,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|